Akzo Nobel N.V. (AKZOY) reports earnings on April 21, 2026, as the global paints and coatings leader faces investor scrutiny. The specialty chemicals company trades at $21.15 with a $32.57 billion market cap. With no consensus estimates available for this quarter, we examine historical performance patterns and key metrics. Recent quarters show mixed results, with the company beating EPS expectations in two of the last four reports. Revenue trends reveal volatility, ranging from $2.33 billion to $2.86 billion. Investors should focus on margin trends and cash flow generation as the company navigates economic headwinds.
Historical Earnings Performance and Patterns
Akzo Nobel’s recent earnings history reveals inconsistent execution. The company has beaten EPS expectations twice while missing once, with one quarter showing no estimates available.
Recent EPS Trends
The most recent quarter (February 2026) showed EPS of $0.22 against a $0.29 estimate, representing a 24% miss. However, the prior quarter (July 2025) delivered $0.43 versus $0.47 expected, a smaller 9% miss. In April 2025, the company beat with $0.33 EPS against $0.30 guidance. This pattern suggests inconsistent operational execution and potential guidance conservatism.
Revenue Performance Analysis
Revenue results show greater volatility than earnings. The February 2026 quarter generated $2.76 billion, beating the $2.33 billion estimate by 18%. The July 2025 quarter delivered $2.63 billion against $2.67 billion expected, a 1% miss. April 2025 saw $2.86 billion revenue, beating $2.62 billion estimates by 9%. Revenue beats appear more frequent than EPS beats, suggesting pricing power but margin pressure.
What to Expect: April 21 Earnings Outlook
With no consensus estimates published for this quarter, investors must rely on historical trends and forward guidance. Based on recent performance, the company faces elevated expectations.
Earnings Per Share Expectations
Given the $0.22 EPS in February and $0.43 in July, a reasonable midpoint estimate would be $0.30-$0.35 for the current quarter. The company’s trailing twelve-month EPS stands at $1.44, suggesting quarterly averages near $0.36. If management maintains conservative guidance, beating is possible. However, the February miss indicates operational challenges that may persist.
Revenue Guidance and Trends
Historical revenue averaging $2.67 billion suggests similar expectations for this quarter. The company’s trailing revenue per share of $19.73 supports this range. Investors should monitor whether the company maintains pricing despite potential demand softness in decorative paints and specialty coatings markets.
Key Metrics and Financial Health
Akzo Nobel’s financial position reveals both strengths and concerns. The company maintains a solid balance sheet but faces profitability headwinds.
Profitability and Margins
The net profit margin stands at 6.2%, down from historical levels, indicating margin compression. Operating margin of 8.0% reflects cost pressures in raw materials and labor. The company’s return on equity of 14.5% remains respectable but shows declining efficiency. Gross margin of 39.9% provides cushion, but SG&A expenses at 31.9% of revenue consume significant profits.
Cash Flow and Liquidity
Operating cash flow per share of $1.74 supports dividend payments of $0.64 per share, yielding 3.6%. Free cash flow of $1.14 per share covers capital expenditures adequately. The current ratio of 1.44 indicates solid short-term liquidity. However, debt-to-equity of 1.04 suggests moderate leverage that limits financial flexibility during downturns.
Meyka AI Grade and Investment Perspective
Meyka AI rates AKZOY with a grade of B+, reflecting balanced fundamentals with notable concerns. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating suggests the stock offers moderate value but carries execution risk.
What the B+ Grade Means
The B+ rating indicates the company performs adequately relative to peers but faces headwinds. Strong DCF valuation (5/5 score) and solid ROA (5/5) offset weak valuation multiples. The PE ratio of 14.7 appears reasonable, but the price-to-book of 1.98 suggests limited margin of safety. Analyst consensus leans neutral with two “Hold” ratings and no upgrades or downgrades recently.
Technical Setup and Price Action
The stock gained 3.4% recently, trading near 50-day moving average of $21.03. RSI of 61.8 suggests moderate momentum without overbought conditions. The stock trades 13.6% below its 52-week high of $24.52, indicating weakness from recent peaks. Year-to-date performance is down 8.6%, underperforming the broader market.
Final Thoughts
Akzo Nobel’s April 21 earnings report shows mixed performance with pricing strength but profitability challenges. The company historically beats revenue estimates more than EPS targets. Investors should monitor margin trends, cash flow, and management guidance. At $21.15, the stock offers reasonable valuation but limited upside without operational improvement. Key focus areas include raw material costs, demand in decorative and specialty coatings, and capital allocation plans. These factors will determine if the stock can recover toward its $24.52 52-week high.
FAQs
What were Akzo Nobel’s recent EPS results?
February 2026: $0.22 EPS (missed $0.29 estimate). July 2025: $0.43 EPS (missed $0.47 estimate). April 2025: $0.33 EPS (beat $0.30 estimate). The company demonstrates inconsistent earnings execution with two misses in three quarters.
How does Akzo Nobel’s revenue performance compare?
February 2026 revenue reached $2.76 billion, beating $2.33 billion estimate by 18%. July 2025 generated $2.63 billion versus $2.67 billion expected. April 2025 delivered $2.86 billion against $2.62 billion guidance. Revenue beats occur more frequently than EPS beats.
What should investors watch in the April 21 earnings?
Monitor gross and operating margins for cost pressures. Track free cash flow and dividend sustainability. Listen for guidance on raw material costs, decorative and specialty coatings demand, and capital expenditure plans. Compare results against $0.30-$0.35 EPS range.
What does the B+ Meyka AI grade mean?
The B+ rating reflects balanced fundamentals with execution risk. Strong DCF valuation and ROA offset weak valuation multiples. The grade considers S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus, suggesting moderate value with caution.
Is Akzo Nobel stock undervalued at $21.15?
PE ratio of 14.7 appears reasonable, but price-to-book of 1.98 offers limited margin of safety. Stock trades 13.6% below 52-week high and down 8.6% year-to-date. Valuation depends on management’s ability to restore margin expansion and earnings growth.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)